7Baggers

We provide you with 20 years of free, institutional-grade data for NEO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NEO. Explore the full financial landscape of NEO stock.

Reported DateCIKTickerType
2025-07-291077183NEO10-QUrl
2025-04-291077183NEO10-QUrl
2025-02-181077183NEO10-KUrl
2024-11-051077183NEO10-QUrl
2024-07-301077183NEO10-QUrl
2024-04-301077183NEO10-QUrl
2024-02-201077183NEO10-KUrl
2023-11-061077183NEO10-QUrl
2023-08-081077183NEO10-QUrl
2023-05-091077183NEO10-QUrl
2023-02-241077183NEO10-KUrl
2022-11-081077183NEO10-QUrl
2022-08-091077183NEO10-QUrl
2022-05-091077183NEO10-QUrl
2022-02-251077183NEO10-KUrl
2021-11-041077183NEO10-QUrl
2021-08-091077183NEO10-QUrl
2021-05-061077183NEO10-QUrl
2021-02-251077183NEO10-KUrl
2020-10-291077183NEO10-QUrl
2020-07-311077183NEO10-QUrl
2020-04-291077183NEO10-QUrl
2020-02-281077183NEO10-KUrl
2019-11-131077183NEO10-QUrl
2019-08-071077183NEO10-QUrl
2019-05-081077183NEO10-QUrl
2019-02-261077183NEO10-KUrl
2018-11-061077183NEO10-QUrl
2018-08-061077183NEO10-QUrl
2018-05-081077183NEO10-QUrl
2018-03-131077183NEO10-KUrl
2017-11-131077183NEO10-QUrl
2017-08-071077183NEO10-QUrl
2017-05-091077183NEO10-QUrl
2017-03-141077183NEO10-KUrl
2016-11-071077183NEO10-QUrl
2016-08-051077183NEO10-QUrl
2016-05-101077183NEO10-QUrl
2016-03-151077183NEO10-KUrl
2015-11-061077183NEO10-QUrl
2015-07-311077183NEO10-QUrl
2015-05-111077183NEO10-QUrl
2015-03-031077183NEO10-KUrl
2014-11-041077183NEO10-QUrl
2014-07-291077183NEO10-QUrl
2014-05-121077183NEO10-QUrl
2014-02-241077183NEO10-KUrl
2013-10-301077183NEO10-QUrl
2013-08-021077183NEO10-QUrl
2013-05-131077183NEO10-QUrl
2013-02-211077183NEO10-KUrl
2012-11-051077183NEO10-QUrl
2012-11-051077183NEOS-1Url
2012-08-061077183NEO10-QUrl
2012-05-141077183NEO10-QUrl
2012-03-121077183NEO10-KUrl
2011-10-251077183NEO10-QUrl
2011-07-261077183NEO10-QUrl
2011-05-021077183NEO10-QUrl
2011-02-231077183NEO10-KUrl
2010-10-291077183NEO10-QUrl
2010-08-161077183NEO10-QUrl
2010-05-051077183NEOS-1Url
2010-05-041077183NEO10-QUrl
2010-03-291077183NEO10-KUrl
2009-11-231077183NEO10-QUrl
2009-08-071077183NEO10-QUrl
2009-05-141077183NEO10-QUrl
2009-04-141077183NEO10-KUrl
2008-11-281077183NEOS-1Url
2008-11-071077183NEO10-QUrl
2008-08-141077183NEO10-QUrl
2008-05-151077183NEO10-QUrl

NeoGenomics, Inc
(NASDAQ:NEO) 

NEO stock logo

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceuti...

Founded: 2002
Full Time Employees: 1,700
CEO: Douglas M. Van Oort  
Sector: Healthcare
Industry: Diagnostics & Research
PharmaceuticalsCancer DetectionGenomics
Share this website to your friends
The information provided in this report about NEO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.